摘要
最近多种组学技术的进步和大规模并行测序的出现为精密医学的实施提供了技术支持。精准医学强调,通过强大的检测手段和临床特征的整合,异质性疾病可以很好地划分为更精确的亚型,因此临床医师应该为疾病亚型人群制定更准确的诊断和治疗策略,以最大限度地提高疗效并尽量减少不必要的副作用。肿瘤学处于精准医学的前沿,因为恶性肿瘤具有显着的异质性,并且是全国乃至全世界的主要死亡原因之一。肝细胞癌(HCC)的发病率和死亡率是一种非常不均匀的恶性肿瘤,在世界范围内不断增加,这使其成为一个重要的公共卫生问题。这种异质性影响关键信号通路,驱动表型变异,影响肿瘤进化,并对HCC治疗构成严重挑战。精准医学的应用将对HCC的诊断和治疗策略产生一定的影响。在此,我们总结了精准医学概念下高危人群筛查,预防,诊断,分期和治疗HCC的更新和挑战。
关键词: 肝细胞癌,精准医学,异质性,诊断和治疗策略,靶向治疗,免疫治疗
Current Medicinal Chemistry
Title:Precision Medicine: Update on Diagnosis and Therapeutic Strategies of Hepatocellular Carcinoma
Volume: 25 Issue: 17
关键词: 肝细胞癌,精准医学,异质性,诊断和治疗策略,靶向治疗,免疫治疗
摘要: Recent advances in multiple omics technologies and the advent of massively parallel sequencing provide technical supports for the implementation of precision medicine. The precision medicine emphasizes that heterogeneous diseases can be well classified into more precise subtypes by the powerful detection methods and integration of clinical features, so that the clinicians should develop more accurate diagnosis and therapeutic strategies for the disease subtype population in an effort to maximize the efficacy and minimize the unnecessary side effects. Oncology is at the forefront of precision medicine, as malignant tumors have significant heterogeneity and are among the leading causes of death nationally and worldwide. The incidence and mortality of Hepatocellular Carcinoma (HCC), a kind of extraordinarily heterogeneous malignancy, have been increasing worldwide, making it a major public health concern. Such heterogeneity affects key signaling pathways, driving phenotypic variation, influences tumor evolution, and poses severe challenges to HCC treatment. The application of precision medicine will have certain impact on HCC diagnosis and treatment strategies. Herein, we summarize the updates and challenges in high-risk population screening, prevention, diagnosis, staging and therapy of HCC under the concept of precision medicine.
Export Options
About this article
Cite this article as:
Precision Medicine: Update on Diagnosis and Therapeutic Strategies of Hepatocellular Carcinoma, Current Medicinal Chemistry 2018; 25 (17) . https://dx.doi.org/10.2174/0929867325666180117101532
DOI https://dx.doi.org/10.2174/0929867325666180117101532 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Protein Kinase C ζ Drives Sphingomyelin Metabolism in the Nucleus During Cell Proliferation
Current Chemical Biology The Use of the Zebrafish Model to Aid in Drug Discovery and Target Validation
Current Topics in Medicinal Chemistry Polo-like Kinase 1-targeting Chitosan Nanoparticles Suppress the Progression of Hepatocellular Carcinoma
Anti-Cancer Agents in Medicinal Chemistry The Role of Matrix Metalloproteinase Inhibitors in Ischemia-Reperfusion Injury in the Liver
Current Pharmaceutical Design The Chemistry and Biology of the Bryostatins: Potential PKC Inhibitors in Clinical Development
Current Medicinal Chemistry Anticarcinogenic Actions of Tributyrin, A Butyric Acid Prodrug
Current Drug Targets Emerging Role of the Ubiquitin-proteasome System as Drug Targets
Current Pharmaceutical Design New Spirocyclic Hydroxamic Acids as Effective Antiproliferative Agents
Anti-Cancer Agents in Medicinal Chemistry CEBP Epigenetic Dysregulation as a Drug Target for the Treatment of Hematologic and Gynecologic Malignancies
Current Drug Targets Potential Anticancer Agents. I. Synthesis of Isoxazole Moiety Containing Quinazoline Derivatives and Preliminarily in vitro Anticancer Activity
Anti-Cancer Agents in Medicinal Chemistry Chemistory of Fibrates
Current Chemical Biology Recent Advances in Cancer Therapy: An Overview
Current Pharmaceutical Design Bamboo a Supplement to Human Health: A Comprehensive Review on its Ethnopharmacology, Phytochemistry, and Pharmacological Activity
The Natural Products Journal Enhancing the Cytotoxic Activity of Novel Targeted Therapies – Is There a Role for a Combinatorial Approach?
Current Clinical Pharmacology Risk Factors for Postembolization Syndrome After Transcatheter Arterial Chemoembolization
Current Medical Imaging Paeoniflorin Affects Hepatocellular Carcinoma Progression by Inhibiting Wnt/β-Catenin Pathway through Downregulation of 5-HT1D
Current Pharmaceutical Biotechnology Herbal Phytochemicals as Immunomodulators
Current Immunology Reviews (Discontinued) Anticancer Mechanisms of Bioactive Peptides
Protein & Peptide Letters MiRNA-145 and Its Direct Downstream Targets in Digestive System Cancers: A Promising Therapeutic Target
Current Pharmaceutical Design ANTI-ADHESION Evolves To a Promising Therapeutic Concept in Oncology
Current Medicinal Chemistry